UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer

Frontiers in oncology, 2021-07, Vol.11, p.617874

Ibrahim, Nuhad K

2021

Volltextzugriff (PDF)

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group

The oncologist (Dayton, Ohio), 2020-06, Vol.25 (6), p.e936-e945

2020

Volltextzugriff (PDF)

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

Nature communications, 2017-06, Vol.8 (1), p.15916-15916, Article 15916

2017

Volltextzugriff (PDF)

Phase III Multicenter Clinical Trial of the Sialyl‐TN (STn)‐Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

The oncologist (Dayton, Ohio), 2011-08, Vol.16 (8), p.1092-1100

2011

Volltextzugriff (PDF)

Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4316-4323

2010

Volltextzugriff (PDF)

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Clinical cancer research, 2010-11, Vol.16 (21), p.5351-5361

2010

Volltextzugriff (PDF)

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy

Breast cancer research : BCR, 2018-04, Vol.20 (1), p.27-27, Article 27

2018

Volltextzugriff (PDF)

Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer

Journal of clinical oncology, 2010-04, Vol.28 (12), p.2032-2037

2010

Volltextzugriff (PDF)

Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6019-6026

2005

Volltextzugriff (PDF)

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5983-5992

2005

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Clinical cancer research, 2002-05, Vol.8 (5), p.1038-1044

2002

Volltextzugriff (PDF)

Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Clinical cancer research, 2011-11, Vol.17 (21), p.6822-6830

2011

Volltextzugriff (PDF)

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer

NPJ breast cancer, 2022-04, Vol.8 (1), p.46-46, Article 46

2022

Volltextzugriff (PDF)

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer

Breast cancer research and treatment, 2016-07, Vol.158 (1), p.67-77

2016

Volltextzugriff (PDF)

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

Cancer medicine (Malden, MA), 2020-02, Vol.9 (3), p.1025-1032

2020

Volltextzugriff (PDF)

Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention

European journal of breast health, 2023-10, Vol.19 (4), p.267-273

2023

Volltextzugriff (PDF)

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer

Journal of clinical oncology, 2012-03, Vol.30 (9), p.930-935

2012

Volltextzugriff (PDF)

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

NPJ breast cancer, 2021-03, Vol.7 (1), p.28-28, Article 28

2021

Volltextzugriff (PDF)

Developing anti‐HER2 vaccines: Breast cancer experience

International journal of cancer, 2018-11, Vol.143 (9), p.2126-2132

2018

Volltextzugriff (PDF)

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

Clinical cancer research, 2019-07, Vol.25 (13), p.3996-4013

2019

Volltextzugriff (PDF)

Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience

International journal of cancer, 2021-02, Vol.148 (4), p.961-970

2021

Volltextzugriff (PDF)

Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation

Journal of Cancer, 2017-01, Vol.8 (11), p.2004-2009

2017

Volltextzugriff (PDF)

Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study

Cancer, 2017-04, Vol.123 (7), p.1115-1123

2017

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(153)

Publikationsform

Artikel
(165)
Buchkapitel
(5)

Sprache

Englisch
(170)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(90)
Oncology
(85)
Humans
(83)
Female
(73)
Middle Aged
(58)
Adult
(52)
Aged
(47)
Breast Cancer
(47)
Breast Neoplasms - Drug Therapy
(46)
Breast Neoplasms - Pathology
(38)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Tumors
(26)
Chemotherapy
(24)
Treatment Outcome
(23)
Pharmacology. Drug Treatments
(21)
Antineoplastic Agents
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(20)
Prognosis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

Phase III Multicenter Clinical Trial of the Sialyl‐TN (STn)‐Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers

Evaluation of a 30-Gene Paclitaxel, Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy Response Predictor in a Multicenter Randomized Trial in Breast Cancer

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer

Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-free, Protein-stabilized, Nanoparticle Formulation of Paclitaxel

Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention

Phase III Trial Evaluating Weekly Paclitaxel Versus Docetaxel in Combination With Capecitabine in Operable Breast Cancer

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases

Developing anti‐HER2 vaccines: Breast cancer experience

Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

Effects of systemic therapy and local therapy on outcomes of 873 breast cancer patients with metastatic breast cancer to brain: MD Anderson Cancer Center experience

Rapid Breast Cancer Disease Progression Following Cyclin Dependent Kinase 4 and 6 Inhibitor Discontinuation

Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study

Suchergebnisse filtern